Microwave Ablation for Pulmonary Metastases From Colorectal Cancer
NCT ID: NCT02502630
Last Updated: 2016-08-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
32 participants
INTERVENTIONAL
2010-06-30
2015-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for Colorectal Cancer Liver Metastases
NCT02419677
Translational Research in Identifying Molecular Mechanisms for Rectal Cancer Metastasis
NCT02979795
Stereotactic Body Radiation Therapy vs. Microwave Ablation for Colorectal Cancer Patients With Metastatic Disease in the Liver
NCT03654131
CAR-T Cell Immunotherapy in MUC1 Positive Solid Tumor
NCT02617134
Consolidative Radiotherapy for Colorectal Cancer Liver Metastases Receiving Surgery or Radiofrequency Ablation
NCT03135652
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Treated with microwave ablation
Patients undergoing MWA for pulmonary metastases from colorectal cancer.
microwave ablation
pulmonary metastases from colorectal cancer are destructed/ablated using microwave ablation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
microwave ablation
pulmonary metastases from colorectal cancer are destructed/ablated using microwave ablation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* diagnosis by CT, and confirmed by percutaneous puncture biopsy.
* Age range 18-70 years old.
* Eastern Cooperative Oncology Group performance status 0-1.
* Life expectancy of more than 3 months.
* Adequate organ function.
Exclusion Criteria
* Life expectancy less than 3 months
* Patients with cardiac pacemaker, cerebral aneurysm clips, implanted electronic instruments or other metal materials.
* Coagulopathy with platelet count less than 50000.
* Active infectious disease.
* Age below 18 years.
* Pregnancy of breastfeeding.
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The First People's Hospital of Changzhou
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jingting Jiang, PD
Role: STUDY_DIRECTOR
The First People's Hospital of Changzhou
References
Explore related publications, articles, or registry entries linked to this study.
Cheng G, Shi L, Qiang W, Wu J, Ji M, Lu Q, Li X, Xu B, Jiang J, Wu C. The safety and efficacy of microwave ablation for the treatment of CRC pulmonary metastases. Int J Hyperthermia. 2018 Jun;34(4):486-491. doi: 10.1080/02656736.2017.1366553. Epub 2017 Nov 16.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CRC-MW-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.